US body begins probe into Elan accounting

The US Securities and Exchange Commission has launched an investigation into alleged ‘Enron-style’ accounting practices in the Irish pharmaceutical firm Elan.

The move follows a report in the Wall Street Journal two weeks ago which accused the company of registering its loss-making enterprises in the accounts of myriad partnerships rather than in Elan’s own accounts.